REQUEST A DEMO
Total
USD $0.00
Search more companies

Tis Farmaceutic SRL (Romania)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Tis Farmaceutic SRL Profile Updated: August 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Tis Farmaceutic SRL is a company based in Romania, with its head office in Bucharest. It operates in the Pharmaceutical Preparation Manufacturing industry. The company was established on December 16, 1994. 55 (2022) employees currently work for Tis Farmaceutic SRL. From the latest financial highlights, Tis Farmaceutic SRL reported a net sales revenue increase of 12.04% in 2023. There was a total negative growth of 2.08% in Tis Farmaceutic SRL’s total assets over the same period. The enterprise’s net profit margin increased by 3.74% in 2023.

Headquarters
Strada Industriilor Nr. 16
Bucharest; Bucharest; Postal Code: 032895

Contact Details: Purchase the Tis Farmaceutic SRL report to view the information.

Basic Information
Total Employees:
Purchase the Tis Farmaceutic SRL report to view the information.
Outstanding Shares:
Purchase the Tis Farmaceutic SRL report to view the information.
Registered Capital:
Purchase the Tis Farmaceutic SRL report to view the information.
Incorporation Date:
December 16, 1994
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Administrator
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Tis Farmaceutic SRL report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RON. Absolute financial data is included in the purchased report.
Net sales revenue
12.04%
Total operating revenue
14.85%
Operating profit (EBIT)
64.36%
EBITDA
48.81%
Net Profit (Loss) for the Period
67.23%
Total assets
-2.08%
Total equity
-36.35%
Operating Profit Margin (ROS)
4.15%
Net Profit Margin
3.74%
Return on Equity (ROE)
32.57%
Quick Ratio
-0.32%
Cash Ratio
-0.21%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?